Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 26, 2006
View Archived Issues
Istradefylline shows potential in restless legs syndrome
Read More
XP-13512 improves restless legs syndrome symptoms in polysomnography trial
Read More
Transgene and NCI sign melanoma CRADA letter of intent
Read More
Enrollment completed in study of DAC:GRF for HIV-associated lipodystrophy
Read More
Affibody and GE Healthcare enter research agreement
Read More
PharmaGap seeks to outlicense or sell PhG-alpha1
Read More
Positive findings in European study of Repel-CV
Read More
Corgentech changes name to Anesiva
Read More
Enrollment open in phase IIa study of NCX-1000 in portal hypertension
Read More
Phase I study of CR011-vcMMAE for melanoma commences
Read More
Preclinical findings for Mymetics' HIV-AIDS prophylactic vaccine candidate
Read More
Desonate NDA accepted for filing
Read More
Compound Therapeutics changes name to Adnexus Therapeutics
Read More
Bone loss treatment ACE-011 enters phase I
Read More
Clearance for phase I/II trial protocol of AMZ-0026 in HIV patients
Read More
Phase I study cleared to begin for CT-322 in cancer
Read More
DG-041 begins phase II program for peripheral artery disease
Read More
AA-4500 highly effective in treatment of Dupuytren's contracture
Read More
bPiDDB blocks nicotine-induced dopamine release in the nucleus accumbens
Read More
Novel human anticocaine monoclonal antibody limits cocaine distribution to the brain
Read More
FDA approval for extended- and immediate-release oxymorphone hydrochloride
Read More
Accelerated approval for Prezista in HIV combination therapy
Read More
Lumigan approved for first-line use
Read More
Recent patents describe novel therapeutic agents for atopic dermatitis, psoriasis
Read More
Novel treatments for inflammatory disorders claimed in recent patents
Read More
Recent patents disclose new therapeutic agents for psychological disorders
Read More
Fenofibrate/metformin combination effective in patients with metabolic syndrome
Read More
Extract from Artemisia dracunculus shows promising antidiabetic properties
Read More
Favorable pharmacokinetic profile of apricitabine in healthy subjects
Read More
Novel topoisomerase II inhibitor shows potent antitumor activity in vivo
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe